1. Mol Cell Endocrinol. 2020 Jan 1;499:110591. doi: 10.1016/j.mce.2019.110591.
Epub  2019 Sep 20.

Metformin has a direct effect on ovarian cells that is dependent on organic 
cation transporters.

Di Pietro M(1), Velazquez C(1), Matzkin ME(1), Frungieri MB(2), Peña MG(3), de 
Zúñiga I(3), Pascuali N(1), Irusta G(1), Bianchi MS(1), Parborell F(1), 
Abramovich D(4).

Author information:
(1)Instituto de Biología y Medicina Experimental-Consejo Nacional de 
Investigaciones Científicas y Técnicas (IByME-CONICET), Ciudad Autónoma de 
Buenos Aires, Argentina.
(2)Instituto de Biología y Medicina Experimental-Consejo Nacional de 
Investigaciones Científicas y Técnicas (IByME-CONICET), Ciudad Autónoma de 
Buenos Aires, Argentina; Cátedra de Química, Ciclo Básico Común, Universidad de 
Buenos Aires, Ciudad de Buenos Aires, Argentina.
(3)Centro Médico Pregna Medicina Reproductiva. Ciudad Autónoma de Buenos Aires, 
Argentina.
(4)Instituto de Biología y Medicina Experimental-Consejo Nacional de 
Investigaciones Científicas y Técnicas (IByME-CONICET), Ciudad Autónoma de 
Buenos Aires, Argentina. Electronic address: abramovich@dna.uba.ar.

Metformin (MET) is the most widely prescribed hypoglycemic drug in type 2 
diabetes and Polycystic Ovary Syndrome. Besides its effects on glucose 
metabolism, MET exerts beneficial effects on these patients' fertility. However, 
the exact mechanisms of action of MET on female fertility are still unclear. In 
this work, we analyzed a possible direct effect of MET on ovarian cells. We 
found expression of the organic cation transporters OCT1, OCT2 and OCT3, 
responsible for MET uptake into the cells, in rat granulosa cells and human 
cumulus cells. Furthermore, MET increased pAMPK and decreased VEGF levels both 
in vivo and in rat granulosa cells in culture. These last effects were reversed 
when OCTs were inhibited. Our results suggest that MET acts directly on ovarian 
cells regulating cell metabolism and VEGF expression. Our findings are relevant 
to optimize PCOS fertility treatment and to explore ovarian MET actions in other 
female pathologies.

Copyright © 2019 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.mce.2019.110591
PMID: 31546019 [Indexed for MEDLINE]
